Cargando…

MUG Mel3 Cell Lines Reflect Heterogeneity in Melanoma and Represent a Robust Model for Melanoma in Pregnancy

Melanomas are aggressive tumors with a high metastatic potential and an increasing incidence rate. They are known for their heterogeneity and propensity to easily develop therapy-resistance. Nowadays they are one of the most common cancers diagnosed during pregnancy. Due to the difficulty in balanci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schrom, Silke, Hebesberger, Thomas, Wallner, Stefanie Angela, Anders, Ines, Richtig, Erika, Brandl, Waltraud, Hirschmugl, Birgit, Garofalo, Mariangela, Bernecker, Claudia, Schlenke, Peter, Kashofer, Karl, Wadsack, Christian, Aigelsreiter, Ariane, Heitzer, Ellen, Riedl, Sabrina, Zweytick, Dagmar, Kretschmer, Nadine, Richtig, Georg, Rinner, Beate
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8583216/ https://www.ncbi.nlm.nih.gov/pubmed/34768746 http://dx.doi.org/10.3390/ijms222111318

Ejemplares similares

Human melanoma brain metastases cell line MUG-Mel1, isolated clones and their detailed characterization
por: Heitzer, Ellen, et al.
Publicado: (2019)

MUG-Mel2, a novel highly pigmented and well characterized NRAS mutated human melanoma cell line
por: Rinner, Beate, et al.
Publicado: (2017)

In Model, In Vitro and In Vivo Killing Efficacy of Antitumor Peptide RDP22 on MUG-Mel2, a Patient Derived Cell Line of an Aggressive Melanoma Metastasis
por: Wußmann, Maximiliane, et al.
Publicado: (2022)

MUG CCArly: A Novel Autologous 3D Cholangiocarcinoma Model Presents an Increased Angiogenic Potential
por: Schrom, Silke, et al.
Publicado: (2023)

Function and Clinical Implications of Long Non-Coding RNAs in Melanoma
por: Richtig, Georg, et al.
Publicado: (2017)

Two Case Reports of Rare BRAF Mutations in Exon 11 and Exon 15 with Discussion of Potential Treatment Options
por: Richtig, Georg, et al.
Publicado: (2016)

ASCO Congress 2018: melanoma treatment
por: Richtig, Erika
Publicado: (2018)

Circulating Tumor DNA as a Marker for Treatment Response in Metastatic Melanoma Patients Using Next-Generation Sequencing—A Prospective Feasibility Study
por: Berger, Marina, et al.
Publicado: (2021)

Prediction of Response in Melanoma Therapy by Systemic Inflammatory Response – One Size Fits Not All
por: Richtig, Georg, et al.
Publicado: (2017)

Killing of melanoma cells and their metastases by human lactoferricin derivatives requires interaction with the cancer marker phosphatidylserine
por: Riedl, Sabrina, et al.
Publicado: (2014)

Effect of L- to D-Amino Acid Substitution on Stability and Activity of Antitumor Peptide RDP215 against Human Melanoma and Glioblastoma
por: Maxian, Theresa, et al.
Publicado: (2021)

Body mass index may predict the response to ipilimumab in metastatic melanoma: An observational multi-centre study
por: Richtig, Georg, et al.
Publicado: (2018)

Combination Therapy of Novel Oncolytic Adenovirus with Anti-PD1 Resulted in Enhanced Anti-Cancer Effect in Syngeneic Immunocompetent Melanoma Mouse Model
por: Garofalo, Mariangela, et al.
Publicado: (2021)

The Comparison of In Vitro Photosensitizing Efficacy of Curcumin-Loaded Liposomes Following Photodynamic Therapy on Melanoma MUG-Mel2, Squamous Cell Carcinoma SCC-25, and Normal Keratinocyte HaCaT Cells
por: Woźniak, Marta, et al.
Publicado: (2021)

Establishment of clival chordoma cell line MUG-CC1 and lymphoblastoid cells as a model for potential new treatment strategies
por: Gellner, Verena, et al.
Publicado: (2016)

Cannabinoids Reduce Melanoma Cell Viability and Do Not Interfere with Commonly Used Targeted Therapy in Metastatic Melanoma In Vivo and In Vitro
por: Richtig, Georg, et al.
Publicado: (2023)

Interaction of two antitumor peptides with membrane lipids – Influence of phosphatidylserine and cholesterol on specificity for melanoma cells
por: Wodlej, Christina, et al.
Publicado: (2019)

Treatment of Primary and Metastatic Multifocal Mucosal Melanoma of the Oral Cavity with Imatinib
por: Deinlein, Teresa, et al.
Publicado: (2017)

Hedgehog pathway proteins SMO and GLI expression as prognostic markers in head and neck squamous cell carcinoma
por: Richtig, Georg, et al.
Publicado: (2019)

Mitotic checkpoints, MUGs and kinetochores
por: Brinkley, Bill R.
Publicado: (2013)

Antiproliferative Effect of Rottlerin on Sk-Mel-28 Melanoma Cells
por: Daveri, Elena, et al.
Publicado: (2015)

In vitro and in vivo cytotoxic activity of human lactoferricin derived antitumor peptide R-DIM-P-LF11-334 on human malignant melanoma
por: Riedl, Sabrina, et al.
Publicado: (2017)

Predatory journals: Perception, impact and use of Beall’s list by the scientific community–A bibliometric big data study
por: Richtig, Georg, et al.
Publicado: (2023)

Evidence of Human Milk Oligosaccharides in Cord Blood and Maternal-to-Fetal Transport across the Placenta
por: Hirschmugl, Birgit, et al.
Publicado: (2019)

A MUG shot of spindle assembly
por: Short, Ben
Publicado: (2009)

Problems and challenges of predatory journals
por: Richtig, G., et al.
Publicado: (2018)

Loss of Lymphotoxin Alpha-Expressing Memory B Cells Correlates with Metastasis of Human Primary Melanoma
por: Werner, Franziska, et al.
Publicado: (2021)

Overexpression of melanoma inhibitory activity (MIA) enhances extravasation and metastasis of A-mel 3 melanoma cells in vivo
por: Guba, M, et al.
Publicado: (2000)

Landscape of mutations in early stage primary cutaneous melanoma: An InterMEL study
por: Luo, Li, et al.
Publicado: (2022)

Spatiotemporal Analysis of B Cell- and Antibody Secreting Cell-Subsets in Human Melanoma Reveals Metastasis-, Tumor Stage-, and Age-Associated Dynamics
por: Chen, Minyi, et al.
Publicado: (2021)

Minimal residual disease in melanoma: circulating melanoma cells and predictive role of MCAM/MUC18/MelCAM/CD146
por: Rapanotti, Maria Cristina, et al.
Publicado: (2017)

Effects of ursolic and oleanolic on SK-MEL-2 melanoma cells: In vitro and in vivo assays
por: Caunii, Angela, et al.
Publicado: (2017)

Developing an Australian Melanoma Clinical Outcomes Registry (MelCOR): a protocol paper
por: Jobson, Dale, et al.
Publicado: (2022)

In Vitro Cytotoxic Effects of Ferruginol Analogues in Sk-MEL28 Human Melanoma Cells
por: Shao, Luying, et al.
Publicado: (2023)

Synthesis of Novel Shikonin Derivatives and Pharmacological Effects of Cyclopropylacetylshikonin on Melanoma Cells
por: Durchschein, Christin, et al.
Publicado: (2018)

Assessment of the tumourigenic and metastatic properties of SK-MEL28 melanoma cells surviving electrochemotherapy with bleomycin
por: Todorovic, Vesna, et al.
Publicado: (2012)

Characterisation and validation of Mel38; A multi-tissue microRNA signature of cutaneous melanoma
por: Van Laar, Ryan, et al.
Publicado: (2019)

InterMEL: An international biorepository and clinical database to uncover predictors of survival in early-stage melanoma
por: Orlow, Irene, et al.
Publicado: (2023)

Piezo1 Activation Prevents Spheroid Formation by Malignant Melanoma SK-MEL-2 Cells
por: Vasileva, Valeria Y., et al.
Publicado: (2023)

The novel myxofibrosarcoma cell line MUG-Myx1 expresses a tumourigenic stem-like cell population with high aldehyde dehydrogenase 1 activity
por: Lohberger, Birgit, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_vpseuluj8n07a3r4nf3q8k6c7o